CRISPR Platform retweeted
Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases
HELIX: a newly engineered #CRISPR-associated transposases (CASTs) with high integration product purity and genome-wide specificity.
nature.com/articles/s41587-0…
CRISPR Platform retweeted
🚨Preprint alert from #CRISPRBerlin🚨: Combining different CRISPR-nucleases for simultaneous non-viral knock-in and base editing prevents translocations in multiplex-edited CAR T cells. tinyurl.com/5by84ybh
Not just one but many CRISPRs are amazing.
A short thread 👇🧵
1/8
CRISPR Platform retweeted
Great overview of gene editing and gene therapy approaches marching toward the clinic.
Also some great insights about viral vs. non-viral delivery: nature.com/articles/s41587-0…
CRISPR Platform retweeted
Just published @Nature
1st #CRISPR genome editing of immune T-cells to treat cancer, individualized for 16 patients with solid tumors, with some success
nature.com/articles/s41586-0…
nature.com/articles/d41586-0…
by @heidiledford
CRISPR Platform retweeted
RADARS is a new RNA-sensing system developed by @omarabudayyeh, @jgooten + Fei Chen @broadinstitute that allows scientists to detect and target specific cell types and states, opening up potential applications in diagnostics and therapeutics. 🧬 mcgovern.mit.edu/2022/10/27/…
CRISPR Platform retweeted
The end of PCR machines?
Engineered helicase replaces thermocycler in DNA amplification while retaining desired PCR characteristics
doi.org/10.1038/s41467-022-3…
CRISPR Platform retweeted
Our paper is out! New recombinases for large DNA integration in human cells nature.com/articles/s41587-0…
We discovered thousands of recombinases and their DNA targets by searching in mobile genetic elements🧬🦠
Our experiments showed some are promising tools for genome engineering🖋️
CRISPR Platform retweeted
Do you want to learn where the gene editing field is heading? Please join us for this online event! Outstanding speakers lineup, *FREE* registration and several AWARDS for abstract submission: deadline *October 8th*
Please retweet! #CRISPR hsph.harvard.edu/pqg-confere…
CRISPR Platform retweeted
Engineered CRISPR prime editors with compact, untethered reverse transcriptases go.nature.com/3SCy1Fw
CRISPR Platform retweeted
Orbital: an RNA toolbox for vaccines and protein replacement with technology from @Stanford and @BeamTx, and backed by Arch. An Emerging Company Profile by BioCentury's Richard Guy @NTAPGuy buff.ly/3DHgese
CRISPR Platform retweeted
Combinations of single-stranded DNA repair templates and small molecules markedly enhance genome editing go.nature.com/3dS9NYC
CRISPR Platform retweeted
A growing pipeline of mRNA therapeutics is entering clinical trials, in particular systemic delivery of protein replacement therapy for rare monogenic disorders, and cytokines or antibodies for cancer immunotherapy - find out more in our latest news story go.nature.com/3Uq3VXu
CRISPR Platform retweeted
We just published a review on bacteriophage genome engineering methods, including various CRISPR approaches. Great work by PhD student Marina Mahler now in @PeterFineran’s group. Thanks @AnaRitaMCosta, Sam and Peter for contributing.
cell.com/trends/biotechnolog…
CRISPR Platform retweeted
Today we report in @NatureBiotech the high-throughout phase-assisted continuous evolution of compact Cas9 variants that require only single-nucleotide pyrimidine PAM sequences (N4TN and N4CN). This work was a terrific collaboration with @MoKhalilLab. 1/8)
drive.google.com/file/d/1qmF…
CRISPR Platform retweeted
Today in @BiochemistryACS, we share a perspective on emergent kilobase-scale genome editing technologies - including dual-flap prime editing, recombinases, and transposases (+ their variations). pubs.acs.org/doi/10.1021/acs…
CRISPR Platform retweeted
Reprogramming of antibody responses in mice is achieved via adeno-associated virus delivery of SaCas9, single guide RNA (sgRNA) and a repair template targeting immunoglobulin genes #NBTNV go.nature.com/3aMEbSw
CRISPR Platform retweeted
Immunocompromised patients continue to face ongoing risks from COVID-19. In this @politico article, sponsored by AstraZeneca, Iskra Reic, EVP, Vaccines and Immune Therapies talks about policy action to protect this community: know.az/3CzEKey
CRISPR Platform retweeted
Gene therapies, the potentially curative "miracles of medicine," are hitting stride with 40-50 expected to be approved by 2030. But their up front costs remains a formidable challenge, despite favorable cost-benefit analyses
economist.com/briefing/2022/…
CRISPR Platform retweeted
An assay leveraging strand-displacement reactions and enzymatic amplification for the recognition of viral RNA and implemented on origami paper allows for the fast colorimetric detection of SARS-CoV-2 variants, with single-nucleotide specificity.
nature.com/articles/s41551-0…



























